Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × TP protocol × Other solid neoplasm × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Head & Neck 1 Gastrointestinal 1

Conditions

Solid Tumor Cancer 1

Interventions

Injections 9 Oxaliplatin 6 tislelizumab 5 Capecitabine 5 fludarabine 4 Pemetrexed 4 Cisplatin 4 Carboplatin 4 toripalimab 3 pembrolizumab 3 Paclitaxel 3 Leucovorin 3 Interviews as Topic 3 Interleukin-2 3 Immune Checkpoint Inhibitors 3 Fluorouracil 3 Fluorodeoxyglucose F18 3 Cyclophosphamide 3 envafolimab 2 Palliative Care 2 Methods 2 Iodine-125 2 Educational Status 2 Early Intervention, Educational 2 Drug Therapy 2 Docetaxel 2 Cryosurgery 2 trastuzumab deruxtecan 1 spartalizumab 1 somatostatin receptor 2 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06649448 2024-10-18

EF-001

Shandong Cancer Hospital and Institute

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡